Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 04-2014 | 01-2014 | 10-2013 | 07-2013 | 04-2013 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 84 | -35 | 209 | 1 | -17 |
| Other Working Capital | 110 | -9 | 201 | 24 | -15 |
| Other Operating Activity | 94 | 69 | -416 | 0 | 14 |
| Operating Cash Flow | $288 | $25 | $-6 | $26 | $-18 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $0 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $0 | $0 | $0 |
| Beginning Cash Position | 364 | 339 | 345 | 319 | 337 |
| End Cash Position | 651 | 364 | 339 | 345 | 319 |
| Net Cash Flow | $288 | $25 | $-6 | $26 | $-18 |
| Free Cash Flow | |||||
| Operating Cash Flow | 288 | 25 | -6 | 26 | -18 |
| Free Cash Flow | 288 | 25 | -6 | 26 | -18 |